Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-038, 39)
Fangsheng Pharmaceutical\'s announcement on the holding of the results briefing for the third quarter of 2024
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024
Fangsheng Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical
Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical
Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Directors of Fangsheng Pharmaceutical in 2024
Fangsheng Pharmaceutical: Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)
Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the 5th Fangsheng Pharmaceutical Supervisory Board in 2024
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s Announcement on the Transfer of Drug Ownership
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 8th Interim Meeting of the 5th Board of Directors in 2024)
Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical in 2024
Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)
Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 5th Board of Directors at the 8th Interim Meeting in 2024)
Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Directors of Fangsheng Pharmaceutical in 2024
Fangsheng Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-037)
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-035, 36)
Fangsheng Pharmaceutical\'s dividend management system (reviewed and approved by the 2nd Extraordinary General Meeting of Shareholders in 2024)
Announcement of Fangsheng Pharmaceutical on participating in the 2024 Investor Online Group Reception Day in Hunan
Announcement of Resolutions of the 7th Interim Meeting of the Fifth Supervisory Board of Fangsheng Pharmaceutical in 2024
No Data
No Data